New directions in the drug treatment of schizophrenia: metabotropic glutamate receptors

被引:0
|
作者
Schoepp, D. [1 ]
机构
[1] Eli Lilly & Co, Neurosci Res, Indianapolis, IN 46285 USA
关键词
D O I
10.1016/S0924-977X(06)70056-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S179 / S179
页数:1
相关论文
共 50 条
  • [1] Metabotropic Glutamate Receptors: Potential Drug Targets for the Treatment of Schizophrenia
    Chavez-Noriega, Laura E.
    Schaffhauser, Herve
    Campbell, Una C.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (03) : 261 - 281
  • [2] Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia
    Chaki, Shigeyuki
    Hikichi, Hirohiko
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (02) : 94 - 102
  • [3] Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia
    Dogra, Shalini
    Conn, P. Jeffrey
    [J]. MOLECULAR PHARMACOLOGY, 2022, 101 (05) : 275 - 285
  • [4] Activation of metabotropic glutamate 2/3 receptors as a new approach for the treatment of schizophrenia
    Monn, James A.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [5] Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia
    Conn, P. Jeffrey
    Lindsley, Craig W.
    Jones, Carrie K.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (01) : 25 - 31
  • [6] Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia
    Bita Moghaddam
    [J]. Psychopharmacology, 2004, 174 : 39 - 44
  • [7] Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia
    Moghaddam, B
    [J]. PSYCHOPHARMACOLOGY, 2004, 174 (01) : 39 - 44
  • [8] Metabotropic glutamate receptors as drug targets for the treatment of absence epilepsy
    Ngomba, Richard Teke
    van Luijtelaar, Gilles
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2018, 38 : 43 - 50
  • [9] Metabotropic glutamate receptors as drug targets
    Recasens, Max
    Guiramand, Janique
    Aimar, Rose
    Abdulkarim, Ahmad
    Barbanel, Gerard
    [J]. CURRENT DRUG TARGETS, 2007, 8 (05) : 651 - 681
  • [10] Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment
    Ellaithy, Amr
    Younkin, Jason
    Gonzalez-Maeso, Javier
    Logothetis, Diomedes E.
    [J]. TRENDS IN NEUROSCIENCES, 2015, 38 (08) : 506 - 516